The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity (original) (raw)

Nature volume 492, pages 285–289 (2012)Cite this article

Subjects

Abstract

Human chromosome ends are capped by shelterin, a protein complex that protects the natural ends from being recognized as sites of DNA damage and also regulates the telomere-replicating enzyme, telomerase1,2,3. Shelterin includes the heterodimeric POT1–TPP1 protein, which binds the telomeric single-stranded DNA tail4,5,6,7,8,9. TPP1 has been implicated both in recruiting telomerase to telomeres and in stimulating telomerase processivity (the addition of multiple DNA repeats after a single primer-binding event)9,10,11,12,13,14. Determining the mechanisms of these activities has been difficult, especially because genetic perturbations also tend to affect the essential chromosome end-protection function of TPP1 (refs 15, 16, 17). Here we identify separation-of-function mutants of human TPP1 that retain full telomere-capping function in vitro and in vivo, yet are defective in binding human telomerase. The seven separation-of-function mutations map to a patch of amino acids on the surface of TPP1, the TEL patch, that both recruits telomerase to telomeres and promotes high-processivity DNA synthesis, indicating that these two activities are manifestations of the same molecular interaction. Given that the interaction between telomerase and TPP1 is required for telomerase function in vivo, the TEL patch of TPP1 provides a new target for anticancer drug development.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Palm, W. & de Lange, T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42, 301–334 (2008)
    Article CAS Google Scholar
  2. Greider, C. W. & Blackburn, E. H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337, 331–337 (1989)
    Article ADS CAS Google Scholar
  3. Lingner, J. et al. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276, 561–567 (1997)
    Article CAS Google Scholar
  4. Baumann, P. & Cech, T. R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292, 1171–1175 (2001)
    Article ADS CAS Google Scholar
  5. Houghtaling, B. R., Cuttonaro, L., Chang, W. & Smith, S. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr. Biol. 14, 1621–1631 (2004)
    Article CAS Google Scholar
  6. Liu, D. et al. PTOP interacts with POT1 and regulates its localization to telomeres. Nature Cell Biol. 6, 673–680 (2004)
    Article CAS Google Scholar
  7. Ye, J. Z. et al. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 18, 1649–1654 (2004)
    Article CAS Google Scholar
  8. Lei, M., Podell, E. R. & Cech, T. R. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nature Struct. Mol. Biol. 11, 1223–1229 (2004)
    Article CAS Google Scholar
  9. Wang, F. et al. The POT1–TPP1 telomere complex is a telomerase processivity factor. Nature 445, 506–510 (2007)
    Article ADS CAS Google Scholar
  10. Lue, N. F. Adding to the ends: what makes telomerase processive and how important is it? Bioessays 26, 955–962 (2004)
    Article CAS Google Scholar
  11. Latrick, C. M. & Cech, T. R. POT1–TPP1 enhances telomerase processivity by slowing primer dissociation and aiding translocation. EMBO J. 29, 924–933 (2010)
    Article CAS Google Scholar
  12. Tejera, A. M. et al. TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice. Dev. Cell 18, 775–789 (2010)
    Article CAS Google Scholar
  13. Abreu, E. et al. TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol. Cell. Biol. 30, 2971–2982 (2010)
    Article CAS Google Scholar
  14. Xin, H. et al. TPP1 is a homologue of ciliate TEBP-β and interacts with POT1 to recruit telomerase. Nature 445, 559–562 (2007)
    Article ADS CAS Google Scholar
  15. Denchi, E. L. & de Lange, T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448, 1068–1071 (2007)
    Article ADS CAS Google Scholar
  16. Guo, X. et al. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J. 26, 4709–4719 (2007)
    Article CAS Google Scholar
  17. Hockemeyer, D. et al. Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nature Struct. Mol. Biol. 14, 754–761 (2007)
    Article CAS Google Scholar
  18. Cristofari, G. & Lingner, J. Telomere length homeostasis requires that telomerase levels are limiting. EMBO J. 25, 565–574 (2006)
    Article CAS Google Scholar
  19. Zaug, A. J., Podell, E. R., Nandakumar, J. & Cech, T. R. Functional interaction between telomere protein TPP1 and telomerase. Genes Dev. 24, 613–622 (2010)
    Article CAS Google Scholar
  20. Zhong, F. L. et al. TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell 150, 481–494 (2012)
    Article CAS Google Scholar
  21. Sexton, A. N., Youmans, D. T. & Collins, K. Specificity requirements for human telomere protein interaction with telomerase holoenzyme. J. Biol. Chem.. http://dx.doi:10.1074/jbc.M112.394767jbc.M112.394767 (2012)
  22. Miyoshi, T., Kanoh, J., Saito, M. & Ishikawa, F. Fission yeast Pot1-Tpp1 protects telomeres and regulates telomere length. Science 320, 1341–1344 (2008)
    Article ADS CAS Google Scholar
  23. Moser, B. A., Chang, Y. T., Kosti, J. & Nakamura, T. M. Tel1ATM and Rad3ATR kinases promote Ccq1-Est1 interaction to maintain telomeres in fission yeast. Nature Struct. Mol. Biol. 18, 1408–1413 (2011)
    Article CAS Google Scholar
  24. Yamazaki, H., Tarumoto, Y. & Ishikawa, F. Tel1ATM and Rad3ATR phosphorylate the telomere protein Ccq1 to recruit telomerase and elongate telomeres in fission yeast. Genes Dev. 26, 241–246 (2012)
    Article CAS Google Scholar
  25. Park, J. I. et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460, 66–72 (2009)
    Article ADS CAS Google Scholar
  26. Majerská, J., Sykorova, E. & Fajkus, J. Non-telomeric activities of telomerase. Mol. Biosyst. 7, 1013–1023 (2011)
    Article Google Scholar
  27. Abreu, E., Terns, R. M. & Terns, M. P. Visualization of human telomerase localization by fluorescence microscopy techniques. Methods Mol. Biol. 735, 125–137 (2011)
    Article CAS Google Scholar
  28. Weidenfeld, I. et al. Inducible expression of coding and inhibitory RNAs from retargetable genomic loci. Nucleic Acids Res. 37, e50 (2009)
    Article Google Scholar
  29. Abell, A. N. et al. Rac2D57N, a dominant inhibitory Rac2 mutant that inhibits p38 kinase signaling and prevents surface ruffling in bone-marrow-derived macrophages. J. Cell Sci. 117, 243–255 (2004)
    Article CAS Google Scholar
  30. Berger, S. M. et al. Quantitative analysis of conditional gene inactivation using rationally designed, tetracycline-controlled miRNAs. Nucleic Acids Res. 38, e168 (2010)
    Article Google Scholar
  31. Mossessova, E. & Lima, C. D. Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol. Cell 5, 865–876 (2000)
    Article CAS Google Scholar
  32. Nandakumar, J., Podell, E. R. & Cech, T. R. How telomeric protein POT1 avoids RNA to achieve specificity for single-stranded DNA. Proc. Natl Acad. Sci. USA 107, 651–656 (2010)
    Article ADS CAS Google Scholar
  33. Weidenfeld, I. Inducible microRNA-mediated knockdown of the endogenous human lamin A/C gene. Methods Mol. Biol. 815, 289–305 (2012)
    Article CAS Google Scholar

Download references

Acknowledgements

We thank T. de Lange, M. Terns and S. Langer for suggestions and sharing protocols; T. Nahreini for maintenance of the departmental tissue culture facility; J. Friedman and G. Voeltz for help with confocal microscopy; and A. Berman, S. Borah and M. Nakashima for critical reading of the manuscript. T.R.C. is an investigator of the Howard Hughes Medical Institute (HHMI). J.N. was an HHMI fellow of the Helen Hay Whitney Foundation during a major part of this study and is supported by the National Cancer Institute of the National Institutes of Health under award number K99CA167644. This work was supported in part by US National Institutes of Health grant R01GM29090 to L.A.L. and R01GM099705 to T.R.C.

Author information

Author notes

  1. Caitlin F. Bell
    Present address: Present address: Vanderbilt School of Medicine, M.D. program, 215 Light Hall, Nashville, Tennessee 37232, USA.,
  2. Caitlin F. Bell and Ina Weidenfeld: These authors contributed equally to this work.

Authors and Affiliations

  1. University of Colorado BioFrontiers Institute, Boulder, Colorado 80309, USA,
    Jayakrishnan Nandakumar, Caitlin F. Bell, Ina Weidenfeld, Arthur J. Zaug, Leslie A. Leinwand & Thomas R. Cech
  2. Howard Hughes Medical Institute and Department of Chemistry and Biochemistry, University of Colorado, Boulder, 80309, Colorado, USA
    Jayakrishnan Nandakumar, Caitlin F. Bell, Arthur J. Zaug & Thomas R. Cech
  3. Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, 80309, Colorado, USA
    Ina Weidenfeld, Leslie A. Leinwand & Thomas R. Cech

Authors

  1. Jayakrishnan Nandakumar
  2. Caitlin F. Bell
  3. Ina Weidenfeld
  4. Arthur J. Zaug
  5. Leslie A. Leinwand
  6. Thomas R. Cech

Contributions

J.N. and T.R.C. conceived the project and designed experiments with help from I.W. and L.A.L. on biological aspects. C.F.B. with help from J.N. and A.J.Z. conducted protein purifications, DNA-binding assays and telomerase assays. J.N. and I.W. constructed the stable HeLa cell lines. J.N. performed all remaining experiments including molecular cloning, cell culture, co-IP, TRF analysis and IF–FISH. J.N. and T.R.C. wrote the paper.

Corresponding author

Correspondence toThomas R. Cech.

Ethics declarations

Competing interests

The authors declare competing financial interests: T.R.C., J.N., C.F.B. and I.W. have filed a patent application relating to the identification of the TEL patch of TPP1.

Supplementary information

Supplementary Information

This file contains Supplementary Figures 1-13, a Supplementary Discussion and additional references. Supplementary Figures 2-6 show in vitro DNA-binding and direct telomerase assays with TPP1-OB mutants, Supplementary Figure 7 shows an investigation of telomerase components contributing to TPP1-OB binding, and Supplementary Figures 8-13 show the development, validation, and utilization of the HeLa-based system used to address the biological phenotypes (chromosome end protection, telomere maintenance, and telomerase recruitment) of the TEL patch mutants of TPP1. The Supplementary Discussion describes how telomerase recruitment in budding yeast compares to that in humans and S. pombe. (PDF 9289 kb)

PowerPoint slides

Rights and permissions

About this article

Cite this article

Nandakumar, J., Bell, C., Weidenfeld, I. et al. The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.Nature 492, 285–289 (2012). https://doi.org/10.1038/nature11648

Download citation

This article is cited by

Editorial Summary

A TEL-ling patch on TPP1 telomere protein

The human chromosomal telomere-binding protein TPP1 protein binds telomeric single-stranded DNA and has an essential role in protecting chromosome ends. It is believed to both recruit and stimulate telomerase, the enzyme that replicates chromosome ends. Thomas Cech and colleagues show, using separation-of-function mutants of TPP1, that telomerase binding and telomere capping are independent functions. These mutants identify a small patch of amino acids on the surface of TPP1—the TEL patch—that is required both for binding telomerase and promoting its action. Telomerase is overexpressed in many cancers, making it a prime target for drug development. As it has been proven difficult to inhibit telomerase itself, the TEL patch provides a promising new strategy for anticancer therapy.